பதிவு க்கு இது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பதிவு க்கு இது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பதிவு க்கு இது Today - Breaking & Trending Today

NeuBase Therapeutics' CEO, Dietrich A. Stephan, Ph.D., to Present "Accelerating the Genetic Revolution with a New Class of Synthetic Medicines" at Tribe Public's Event on December 22, 2020

NeuBase Therapeutics' CEO, Dietrich A. Stephan, Ph.D., to Present "Accelerating the Genetic Revolution with a New Class of Synthetic Medicines" at Tribe Public's Event on December 22, 2020
albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.

San Francisco , United States , Dietrich Stephan , Johnf Heerdink Jr , Dietricha Stephan , Tribe Public , Carnegie Mellon University , Translational Genomics Research Institute , Department Of Human Genetics , Neubase Therapeutics Inc , University Of Pittsburgh , Sequoia Capital , Registration For This , Public Presentation , Event Is Now Open , Chief Executive Officer , Neubase Therapeutics , Webinar Event , Genetic Revolution , New Class , Synthetic Medicines , Human Genome Project , Human Genetics , New England Journal , Nature Genetics , Thiel Capital ,

Tribe Public LLC: NeuBase Therapeutics' CEO, Dietrich A. Stephan, Ph.D., to Present Accelerating the Genetic Revolution with a New Class of Synthetic Medicines at Tribe Public's Event on December 22, 2020

(2)
Registration For This FREE Tribe Public Presentation and Q&A Event Is Now Open at NeuBase22.TribePublic.com
SAN FRANCISCO, CA / ACCESSWIRE / December 18, 2020 / Tribe Public announced today that Dietrich Stephan, Ph.D., Chief Executive Officer of NeuBase Therapeutics, Inc. (NASDAQ:NBSE), a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines, will present at Tribe Public s Presentation and Q&A Webinar Event beginning at 8:30 a.m. PDT / 11:30 a.m. EDT on Tuesday, December 22, 2020.
During this complimentary, 30-minute event, Dr. Stephan will deliver his presentation titled
Accelerating the Genetic Revolution with a New Class of Synthetic Medicines. He will also be available for a brief Q&A session. To register for the complimentary event, please visit ....

San Francisco , United States , Dietrich Stephan , Johnf Heerdink Jr , Dietricha Stephan , Tribe Public , Carnegie Mellon University , Translational Genomics Research Institute , Department Of Human Genetics , Neubase Therapeutics Inc , University Of Pittsburgh , Sequoia Capital , Registration For This , Public Presentation , Event Is Now Open , Chief Executive Officer , Neubase Therapeutics , Webinar Event , Genetic Revolution , New Class , Synthetic Medicines , Human Genome Project , Human Genetics , New England Journal , Nature Genetics , Thiel Capital ,